Infectious Diseases News and Research

RSS

Archaeologists find oldest complete example of metastatic cancer in 3,000 year-old skeleton

Archaeologists have found the oldest complete example in the world of a human with metastatic cancer in a 3,000 year-old skeleton.

19 Mar 2014

Children with prenatal methamphetamine exposure 2.8 times more likely to have cognitive problem

In the only long-term, National Institutes of Health-funded study of prenatal methamphetamine exposure and child outcome, researchers found youngsters exposed to the potent illegal drug before birth had increased cognitive problems at age 7.5 years, highlighting the need for early intervention to improve academic outcomes and reduce the potential for negative behaviors, according to the study published online by The Journal of Pediatrics.

18 Mar 2014

More compassion, resources required to help guide treatment choices for congenital heart disease

Based on a survey of parents of children with congenital heart disease, physicians delivering the diagnosis need to do a better job of showing compassion, ensuring parents understand all their options and providing easily understandable information, according to a new study published in the February edition of the journal, Pediatric Cardiology.

18 Mar 2014

Sequencing reveals genetic diversity in hospital-acquired bacterium

Using genome sequencing, National Institutes of Health scientists and their colleagues have tracked the evolution of the antibiotic-resistant bacterium Klebsiella pneumoniae sequence type 258 (ST258), an important agent of hospital-acquired infections.

18 Mar 2014

New research commissioned to create infection control strategy for AMR and antibiotic usage

It is the health system’s nightmare, bubbling just below the surface of our hospitals. Infections are becoming more and more resistant to antibiotics, while secondary infection rates during hospital stays continue to rise.

18 Mar 2014

Patients with both HIV and hepatitis C have 80% higher rates of serious liver disease

A new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in HIV patients otherwise benefitting from antiretroviral therapy (ART) to treat HIV.

18 Mar 2014

Trovagene reports net loss of $1 million for fourth quarter 2013

Trovagene, Inc., a developer of cell-free molecular diagnostics, today reported its financial results for the quarter and the year ended December 31, 2013.

18 Mar 2014

Researchers discover how STAT3 protein breaches antitumor mechanism prior to cancer development

A Stony Brook University-led international team of infectious disease researchers have discovered how a cellular protein, called STAT3, which is overactive in a majority of human cancers, interferes with an antitumor mechanism in cells and therefore promotes the growth of cancer.

18 Mar 2014

Study shows correlation between blood poisoning and risk of blood clots

Every year, almost 10,000 Danes are admitted to hospital with blood poisoning, while more than 3,000 patients become infected while they are hospitalised. New research shows that Danes suffering from blood poisoning risk an extra challenge in the form of an increased risk of suffering a blood clot:

17 Mar 2014

Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize for research on immune system

Michael Reth has won the Paul Ehrlich and Ludwig Darmstaedter Prize, awarded by the Paul Ehrlich Foundation, for his research on the immune system. For the first time since 1996, the prize goes to a scientist working in Germany.

17 Mar 2014

Merck's NOXAFIL injection gets FDA approval for intravenous use

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFIL (posaconazole) injection (18 mg/ mL), a new formulation of NOXAFIL for intravenous (IV) use.

16 Mar 2014

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Knopp Biosciences LLC today announced a second collaboration with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to investigate the eosinophil-lowering effects of the investigational drug dexpramipexole.

13 Mar 2014

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

Although community network studies show that sexual relationships occur between members of "risk groups" -- men who have sex with other men (MSM), people who inject drugs (PWID), non-injection drug users (NIDU) -- and heterosexuals, researchers at New York University's Center for Drug Use and HIV Research (CDUHR) note that little research has been done to help explain how HIV epidemics and programs in one population affect others and how to reduce the risks of transmission.

13 Mar 2014

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Notre Dame biologists Nicole Achee and Neil Lobo are leaders of an international $23 million research grant from the Bill & Melinda Gates Foundation. Their five-year project will generate the data required to show the effectiveness of a new paradigm in mosquito control -spatial repellency - for the prevention of two important mosquito-borne diseases: malaria and dengue fever.

13 Mar 2014

Women who experience gestational diabetes may face increased risk of heart disease later in life

Women who experience gestational diabetes may face an increased risk of early heart disease later in life, even if they do not develop type 2 diabetes or metabolic syndrome subsequent to their pregnancy, according to a Kaiser Permanente study published today in the Journal of the American Heart Association.

13 Mar 2014

EPFL sets up foundation to release antibiotic for tuberculosis

Even though tuberculosis kills more than 1.5 million people every year, the market is not cost-effective for pharmaceutical companies. So EPFL is setting up a foundation to release an antibiotic developed in its own laboratories under EU funding.

12 Mar 2014

UCSF School of Medicine ranked fourth nationwide in research and primary care education

UC San Francisco's School of Medicine ranked fourth nationwide in both research and primary care education this year, according to a new survey conducted by U.S. News & World Report.

11 Mar 2014

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

OpenText, the global leader in Enterprise Information Management (EIM), announced today that it has been selected by the Royal Free London NHS Foundation Trust to manage its scanned legacy case-notes.

11 Mar 2014

Clinipace Worldwide closes merger with Choice Pharma

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide's operational and therapeutic expertise in Asia, a region in high demand by Clinipace's clients.

11 Mar 2014

One person's unique ability provides key insights into immune response to fight HIV

One person's unique ability to fight HIV has provided key insights into an immune response that researchers now hope to trigger with a vaccine, according to findings reported by a team that includes Duke Medicine scientists.

11 Mar 2014

Infectious Diseases News and Research

Archaeologists find oldest complete example of metastatic cancer in 3,000 year-old skeleton

Children with prenatal methamphetamine exposure 2.8 times more likely to have cognitive problem

More compassion, resources required to help guide treatment choices for congenital heart disease

Sequencing reveals genetic diversity in hospital-acquired bacterium

New research commissioned to create infection control strategy for AMR and antibiotic usage

Patients with both HIV and hepatitis C have 80% higher rates of serious liver disease

Trovagene reports net loss of $1 million for fourth quarter 2013

Researchers discover how STAT3 protein breaches antitumor mechanism prior to cancer development

Study shows correlation between blood poisoning and risk of blood clots

Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize for research on immune system

Merck's NOXAFIL injection gets FDA approval for intravenous use

Knopp and NIAID collaborate to investigate eosinophil-lowering effects of dexpramipexole

Programs for heterosexuals who use drugs linked with subsequent lower rates of AIDS incidence

Notre Dame biologists awarded $23M research grant to prevent malaria and dengue fever

Women who experience gestational diabetes may face increased risk of heart disease later in life

EPFL sets up foundation to release antibiotic for tuberculosis

UCSF School of Medicine ranked fourth nationwide in research and primary care education

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

Clinipace Worldwide closes merger with Choice Pharma

One person's unique ability provides key insights into immune response to fight HIV

NGS for Infectious Disease Surveillance eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News